Sources told ET that online pharmacy startup PharmEasy could hit the bourses this year, two years after its previous attempt. The company will discuss its IPO plans with the board next month, including options such as a reverse merger with Thyrocare. It aims to use its improved finances and revamped business model to attract public investors.